Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
-
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Senti Bio to Participate in Upcoming Investor Conferences
-
Senti Bio to Participate in Upcoming Investor Conferences
-
Form 3 Monterey Innovation Acqu For: Sep 29 Filed by: Chardan Monterey Investments LLC
-
Form 4 Monterey Innovation Acqu For: Mar 09 Filed by: Chardan Monterey Investments LLC
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
-
Carisma Therapeutics to Present at Upcoming Healthcare Industry and Investor Conferences in April 2023
-
Better Therapeutics Announces $6.5MM Private Placement
-
Dragonfly Energy Reports Fourth Quarter and Full Year 2022 Financial Results
-
Dragonfly Energy Reports Fourth Quarter and Full Year 2022 Financial Results
-
Market Analysis Endorsement Boosts Prospects of OTR Shipping Optimizer Freight Technologies Inc. (NASDAQ: FRGT)
-
Gardiner Healthcare Acquisitions Corp. Announces Extension
-
Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp
-
8X Upside Projected for Freight Technologies, Inc. (NASDAQ: FRGT)
-
Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023
-
Monterey Bio Acquisition Corp. Announces Rebrand and Management Changes
-
ZeroNox to Become First Public Company of its Kind, Through Merger with The Growth for Good Acquisition Corporation (GFGD)
-
ZeroNox, a Leader in Off-Highway Electrification of Commercial and Industrial Vehicles, to Become First Public Company of its Kind, Through Merger with The Growth for Good Acquisition Corporation
-
Insignia Systems, Inc. Announces Fourth Quarter And Full Year 2022 Financial Results
-
Wallbox Announces Upcoming Events for the Investor Community
-
InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Focus of Chardan Capital Research Report; Maintains Buy Rating, Updates Price Target
-
Chardan Capital Research Maintains Buy on Freight Technologies Inc., Lowers Price Target by $0.25 to $2.00
-
VBL Therapeutics (VBLT) and Notable Labs Announce Definitive Merger Agreement
-
VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement
-
Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment Option
-
ABYC Compliant Lithium Power Systems Made Possible with New Products from Battle Born Batteries
-
ABYC Compliant Lithium Power Systems Made Possible with New Products from Battle Born Batteries
-
Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public Offering
-
Bellevue Life Sciences Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
-
Allurion to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp. (CPUH)
-
Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp.
-
Sonnet BioTherapeutics (SONN) Prices $15M Offering of Common Stock, Warrants
-
Sonnet BioTherapeutics Announces Pricing of $15.0 Million Underwritten Public Offering
-
Today's most important initiations
-
Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model
-
Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model
-
Openmarkets Group to Go Public via Merger with Broad Capital Acquisition Corp (BRAC)
-
Cohen & Company Capital Markets Continues Strong Growth Despite Tumultuous Capital Market Environment
-
Openmarkets, an Australian Trading and Wealth Management Fintech, Signs Definitive Agreement to Combine with Broad Capital Acquisition Corp. (Nasdaq: BRAC)
-
AlphaTime Acquisition Corp Announces the Separate Trading of its Ordinary Shares, Warrants and Rights Commencing January 19, 2023
-
Dragonfly Energy Launches Smart Lithium-Ion Battery Technology Dragonfly IntelLigence™
-
Dragonfly Energy Launches Smart Lithium-Ion Battery Technology Dragonfly IntelLigence™
-
AlphaTime Acquisition Corp Announces Closing of Full Over-allotment Option
-
Form SC 13D/A Dragonfly Energy Holding Filed by: Chardan NexTech Investments 2 LLC
-
AlphaTime Acquisition Corp Announces Closing of $60 Million Initial Public Offering

